Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the safety and effectiveness of galantamine versus placebo in patients with vascular dementia or mixed dementia. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Vascular Dementia

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Alzheimer Disease, Vascular Dementia | Phase 3 | Status: COMPLETED